Have a personal or library account? Click to login
Synthesis and photodegradation studies of analogues of muscle relaxant 1,4-dihydropyridine compounds Cover

Synthesis and photodegradation studies of analogues of muscle relaxant 1,4-dihydropyridine compounds

Open Access
|Aug 2017

References

  1. 1. G. W. Zamponi, J. Striessnig, A. Koschak and A. C. Dolphin, The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential, Pharmacol. Rev.67 (2015) 821–870; DOI: 10.1124/pr.114.009654.10.1124/pr.114.009654463056426362469
  2. 2. E. Carosati, P. Ioan, M. Micucci, F. Broccatelli, G. Cruciani, B. S. Zhorov, A. Chiarini and R. Budriesi, 1,4-Dihydropyridine scaff old in medicinal chemistry, the story so far and perspectives (part 2): Action in other targets and antitargets, Curr. Med. Chem.19 (2012) 4306–4323; DOI: 10.2174/092986712802884204.10.2174/09298671280288420422709009
  3. 3. V. M. Gadotti, C. Bladen, F. X. Zhang, L. Chen, M. G. Gündüz, R. Şimşek, C. Şafak and G. W. Zamponi, Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels, Pflug. Arch. Eur. J. Phys.467 (2015) 2485–2493; DOI: 10.1007/s00424-015-1725-1.10.1007/s00424-015-1725-126286466
  4. 4. P. Ioan, E. Carosati, M. Micucci, G. Cruciani, F. Broccatelli, B. S. Zhorov, A. Chiarini and R. Budriesi, 1,4-Dihydropyridine scaff old in medicinal chemistry, the story so far and perspectives (part 1): Action in ion channels and GPCRs, Curr. Med. Chem.18 (2011) 4901–4922; DOI: 10.2174/092986711797535173.10.2174/09298671179753517322050742
  5. 5. N. Edraki, A. R. Mehdipour, M. Khoshneviszadeh and R. Miri, Dihydropyridines: evaluation of their current and future pharmacological applications, Drug Discov. Today14 (2009) 1058–1066; DOI: 10.1016/j.drudis.2009.08.004.10.1016/j.drudis.2009.08.00419729074
  6. 6. D. Takahashi, L. Oyunzul, S. Onoue, Y. Ito, S. Uchida, R. Simsek, M. G. Gunduz, C. Safak and S. Yamada, Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives, Biol. Pharm. Bull.31 (2008) 473–479; DOI: 10.1248/bpb.31.473.10.1248/bpb.31.47318310913
  7. 7. M. Hosseini, R. Miri, M. Amini, H. Mirkhani, B. Hemmateenejad, S. Ghodsi, E. Alipour and A. Shafiee, Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents, Arch. Pharm.340 (2007) 549–556; DOI: 10.1002/ardp.200600211.10.1002/ardp.20060021117849444
  8. 8. R. A. Coburn, M. Wierzba, M. J. Suto, A. J. Solo, A. M. Triggle and D. J. Triggle, 1,4-Dihydropyridine antagonist activities at the calcium-channel – a quantitative structure activity relationship approach, J. Med. Chem.31 (1988) 2103–2107; DOI: 10.1021/jm00119a009.10.1021/jm00119a0092846838
  9. 9. C. Bladen, V. M. Gadotti, M. G. Gündüz, N. D. Berger, R. Şimşek, C. Şafak and G. W. Zamponi, 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain, Pflug. Arch. Eur. J. Phys.467 (2014) 1237–1247; DOI: 10.1007/s00424-014-1566-3.10.1007/s00424-014-1566-324990197
  10. 10. C. Bladen, M. G. Gündüz, R. Şimşek, C. Şafak and G. W. Zamponi, Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity, Pflug. Arch. Eur. J. Phys.466 (2014) 1355–1363; DOI: 10.1007/s00424-013-1376-z.10.1007/s00424-013-1376-z24149495
  11. 11. C. Safak and R. Simşek, Fused 1,4-dihydropyridines as potential calcium modulatory compounds, Mini Rev. Med. Chem.6 (2006) 747–755; DOI: 10.2174/138955706777698606.10.2174/138955706777698606
  12. 12. R. Simsek, G. S. Oztürk, I. M. Vural, M. G. Gündüz, Y. Sarioglu and C. Safak, Synthesis and calcium modulatory activity of 3-alkyloxy-carbonyl-4-(disubstituted)aryl-5-oxo-1,4,5,6,7,8-hexa-hydroquinoline derivatives, Arch. Pharm.341 (2008) 55–60; DOI: 10.1002/ardp.200700087.10.1002/ardp.200700087
  13. 13. C. Safak, M. G. Gündüz, S. Ö. İlhan, R. Şimşek, F. İşli, Ş. Yıldırım, G. S. Öztürk Fincan, Y. Sarıoğlu and A. Linden, Synthesis and myorelaxant activity of fused 1,4-dihydropyridines on isolated rabbit gastric fundus, Drug Dev. Res.73 (2012) 332–342; DOI: 10.1002/ddr.21024.10.1002/ddr.21024
  14. 14. G. Ioele, M. G. Gündüz, M. De Luca, R. Şimşek, C. Şafak, R. Muzzalupo and G. Ragno, Photodegradation studies of 1,4-dihydropyridine compounds by MCR analysis on UV spectral data, Future Med. Chem.8 (2016) 107–115; DOI: 10.4155/fmc.15.172.10.4155/fmc.15.172
  15. 15. G. Ioele, F. Oliverio, I. Andreu, M. De Luca, M. A. Miranda and G. Ragno, Different photodegradation behavior of barnidipine under natural and forced irradiation, J. Photochem. Photobiol. A Chem. 215 (2010) 205–213; DOI: 10.1016/j.jphotochem.2010.08.019.10.1016/j.jphotochem.2010.08.019
  16. 16. G. Ioele, M. De Luca, F. Oliverio and G. Ragno, Prediction of photosensitivity of 1,4-dihydropyridine antihypertensives by quantitative structure-property relationship, Talanta79 (2009) 1418–1424; DOI: 10.1016/j.talanta.2009.06.009.10.1016/j.talanta.2009.06.009
  17. 17. G. Ragno, C. Vetuschi, A. Risoli and G. Ioele, Application of a classical least-squares regression method to the assay of 1,4-dihydropyridine antihypertensives and their photoproducts, Talanta59 (2003) 375–382; DOI: 10.1016/S0039-9140(02)00526-X.10.1016/S0039-9140(02)00526-X
  18. 18. G. Ragno, M. Veronico and C. Vetuschi, Gas chromatographic and UV derivative determination of nitrendipine and its photodegradation product, Int. J. Pharm.99 (1993) 351–355; DOI: 10.1016/0378-5173(93)90380-X.10.1016/0378-5173(93)90380-X
  19. 19. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Q1A(R2) Stability Testing of New Drug Substances and Products, IFPMA, Geneva 2003.
  20. 20. M. De Luca, G. Ragno, G. Ioele and R. Tauler, Multivariate curve resolution of incomplete fused multiset data from chromatographic and spectrophotometric analyses for drug photostability studies, Anal. Chim. Acta837 (2014) 31–37; DOI: 10.1016/j.aca.2014.05.056.10.1016/j.aca.2014.05.05625000855
  21. 21. M. De Luca, W. Terouzi, F. Kzaiber, G. Ioele, A. Oussama and G. Ragno, Classification of moroccan olive cultivars by linear discriminant analysis applied to ATR-FTIR spectra of endocarps, Int. J. Food Sci. Technol.47 (2012) 1286–1292; DOI: 10.1111/j.1365-2621.2012.02972.x.10.1111/j.1365-2621.2012.02972.x
  22. 22. M. De Luca, S. Mas, G. Ioele, F. Oliverio, G. Ragno and R. Tauler, Kinetic studies of nitrofurazone photodegradation by multivariate curve resolution applied to UV-spectral data, Int. J. Pharm.386 (2010) 99–107; DOI: 10.1016/j.ijpharm.2009.11.003.10.1016/j.ijpharm.2009.11.003
  23. 23. A. Smilde, R. Bro and P. Geladi, Multi-Way Analysis: Applications in the Chemical Sciences, Wiley, Chichester (UK) 2004.10.1002/0470012110
  24. 24. S. Mas, A. de Juan, S. Lacorte and R. Tauler, Photodegradation study of decabromodiphenyl ether by UV spectrophotometry and a hybrid hard- and soft-modelling approach, Anal. Chim. Acta618 (2008) 18–28; DOI: 10.1016/j.aca.2008.04.044.10.1016/j.aca.2008.04.044
  25. 25. R. Tauler, M. Maeder and A. de Juan, Multiset Data Analysis: Extended Multivariate Curve Resolution, in Comprehensive Chemometrics, Chemical and Biochemical Data Analysis, 1st ed. (Eds. S. D. Brown, R. Tauler and B. Walczak), Vol 2, Elsevier, London 2009, pp. 473–505.10.1016/B978-044452701-1.00055-7
  26. 26. V. G. Santos, M. N. Godoi, T. Regiani, F. H. Gama, M. B. Coelho, R. O. de Souza, M. N. Eberlin and S. J. Garden, The multicomponent Hantzsch reaction: Comprehensive mass spectrometry monitoring using charge-tagged reagents, Chem. Eur. J.20 (2014) 12808–12816; DOI: 10.1002/chem.201303065.10.1002/chem.201303065
  27. 27. K. A. Undale, Y. Park, K. Park, D. H. Dagade and D. M. Pore, A revisit to the Hantzsch reaction: Unexpected formation of tetrahydrobenzo[b]pyrans beyond polyhydroquinolines, Synlett6 (2011) 791–796; DOI: 10.1055/s-0030-1259924.10.1055/s-0030-1259924
  28. 28. A. Debache, W. Ghalem, R. Boulcina, A. Belfaitah, S. Rhouati and B. Carboni, An efficient one-step synthesis of 1,4-dihydropyridines via a triphenylphosphine-catalyzed three-component Hantzsch reaction under mild conditions, Tetrahedron Lett.50 (2009) 5248–5250; DOI: 10.1016/j.tetlet.2009.07.018.10.1016/j.tetlet.2009.07.018
  29. 29. A. Saini, S. Kumar and J. S. Sandhu, Hantzsch reaction: Recent advances in Hantzsch 1,4-dihydropyridines, J. Sci. Ind. Res.67 (2008) 95–111.
  30. 30. G. Ioele, M. De Luca and G. Ragno, Photostability of barnidipine in combined cyclodextrin-in-liposome matrices, Future Med. Chem.6 (2014) 35–43; DOI: 10.4155/fmc.13.187.10.4155/fmc.13.187
  31. 31. G. Ragno, A. Risoli, G. Ioele, E. Cione and M. De Luca, Photostabilization of 1,4-dihydropyridine antihypertensives by incorporation into beta-cyclodextrin and liposomes, J. Nanosci. Nanotech.6 (2006) 2979–2985; DOI: 10.1166/jnn.2006.407.10.1166/jnn.2006.407
  32. 32. G. Ragno, M. Veronico and C. Vetuschi, Analysis of nimodipine and its photodegradation product by derivative spectrophotometry and gas chromatography, Int. J. Pharm.119 (1995) 115–119; DOI: 10.1016/0378-5173(94)00399-P.10.1016/0378-5173(94)00399-P
  33. 33. S. Onoue, N. Igarashi, Y. Yamauchi, N. Murase, Y. Zhou, T. Kojima, S. Yamada and Y. Tsuda, In vitro phototoxicity of dihydropyridine derivatives: A photochemical and photobiological study, Eur. J. Pharm. Sci.33 (2008) 262–270; DOI: 10.1016/j.ejps.2007.12.004.10.1016/j.ejps.2007.12.00418207709
DOI: https://doi.org/10.1515/acph-2017-0026 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 341 - 355
Accepted on: May 10, 2017
Published on: Aug 30, 2017
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2017 Miyase Gözde Gündüz, Gaetano Ragno, Rahime Şimşek, Michele De Luca, Cihat Şafak, Fedora Grande, Ahmed El-Khouly, Fatma İşli, Şeniz Yildirim, Gökçe Sevim Öztürk Fincan, Giuseppina Ioele, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.